INR:6602. kabaddi information Another move! Zhongheng Group acquires control of Laimi Pharmaceuticals. Senior executives respond: I was not aware of it The nu ...

INR:5912. lucia loi Analysis on the current status of the development of my country's pharmaceutical logistics industry The total remission rate is over 75%! MEI/Kyorin ...

INR:2906. norsk casino online New opportunities for medical representatives amid COVID-19 pandemic The end-of-year action begins: the government conducts a th ...

Hoppers London️ Gilead intends to acquire CD47 leader Forty Seven, whose stock price rises 33% Listed generic drug companies are being questioned ab ...

Antibiotics are widely used during pregnancy. Recent epidemiological studies suggest that maternal exposure to antibiotics during pregnancy is associated with increased risks of various diseases in ...

Kyorin Pharmaceutical Co. Ltd. has acquired Bayer AG’s phase II obstructive sleep apnea candidate, BAY-2925976, in a deal worth €85M (US$89.3 million) plus sales-based royalties and commercial ...

17, SK Biopharmaceuticals will work with and use Proen’s Artbody platform to develop up to two radiopharma candidates over the next three years. Kyorin in-licenses Bayer’s phase II sleep apnea drug ...

KYORIN Pharmaceutical Co.,Ltd. (JP:4569) has released an update. Discover top-rated stocks from highly ranked analysts with Analyst Top Stocks! Easily identify outperforming stocks and invest ...